Publication of educational materials for centrally authorised medicinal products
From January 1st 2023 and forward – and not retroactively – the Danish Medicines Agency now publishes educational material for medicinal products approved via the centralised procedure. Only educational materials approved after January 1st will be published on our website. This in line with what is already done for nationally approved medicinal products (including MRP and DCP approved medicinal products).
This means that the publication of educational materials is now combined for all medicinal products in Denmark. Please refer to this section: Dansk uddannelsesmateriale (in Danish) for the published Danish educational materials.
It is the responsibility of the marketing authorisation holder to ensure that the education material complies with the conditions of the marketing authorisation. It is also the responsibility of the marketing authorisation holder to ensure that the Danish Medicines Agency have the most recently accepted written education material available for publication.
Please refer to this section: Lægemidler med uddannelsesmateriale (EDUMAT) (in Danish) for further information.